127 related articles for article (PubMed ID: 38619000)
1. Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score.
Gerussi A; Cappadona C; Bernasconi DP; Cristoferi L; Valsecchi MG; Carbone M; Invernizzi P; Asselta R;
Liver Int; 2024 Apr; ():. PubMed ID: 38619000
[TBL] [Abstract][Full Text] [Related]
2. LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis.
Gerussi A; Verda D; Cappadona C; Cristoferi L; Bernasconi DP; Bottaro S; Carbone M; Muselli M; Invernizzi P; Asselta R; On Behalf Of The Italian Pbc Genetics Study Group
J Pers Med; 2022 Sep; 12(10):. PubMed ID: 36294727
[TBL] [Abstract][Full Text] [Related]
3. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Cordell HJ; Fryett JJ; Ueno K; Darlay R; Aiba Y; Hitomi Y; Kawashima M; Nishida N; Khor SS; Gervais O; Kawai Y; Nagasaki M; Tokunaga K; Tang R; Shi Y; Li Z; Juran BD; Atkinson EJ; Gerussi A; Carbone M; Asselta R; Cheung A; de Andrade M; Baras A; Horowitz J; Ferreira MAR; Sun D; Jones DE; Flack S; Spicer A; Mulcahy VL; Byan J; Han Y; Sandford RN; Lazaridis KN; Amos CI; Hirschfield GM; Seldin MF; Invernizzi P; Siminovitch KA; Ma X; Nakamura M; Mells GF; ; ; ; ; ; ;
J Hepatol; 2021 Sep; 75(3):572-581. PubMed ID: 34033851
[TBL] [Abstract][Full Text] [Related]
4. Disease predisposition of human leukocyte antigen class II genes influences the gut microbiota composition in patients with primary biliary cholangitis.
Huang CY; Zhang HP; Han WJ; Zhao DT; Liao HY; Ma YX; Xu B; Li LJ; Han Y; Liu XH; Wang Q; Lou JL; Zhang XD; Zhao J; Li WJ; Liu YM; Yan HP
Front Immunol; 2022; 13():984697. PubMed ID: 36203614
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to genome-wide association analysis identifies genetic associations with primary biliary cholangitis and primary sclerosing cholangitis in Polish patients.
Paziewska A; Habior A; Rogowska A; Zych W; Goryca K; Karczmarski J; Dabrowska M; Ambrozkiewicz F; Walewska-Zielecka B; Krawczyk M; Cichoz-Lach H; Milkiewicz P; Kowalik A; Mucha K; Raczynska J; Musialik J; Boryczka G; Wasilewicz M; Ciecko-Michalska I; Ferenc M; Janiak M; Kanikowska A; Stankiewicz R; Hartleb M; Mach T; Grzymislawski M; Raszeja-Wyszomirska J; Wunsch E; Bobinski T; Mikula M; Ostrowski J
BMC Med Genomics; 2017 Jan; 10(1):2. PubMed ID: 28056976
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk.
Thomas M; Sakoda LC; Hoffmeister M; Rosenthal EA; Lee JK; van Duijnhoven FJB; Platz EA; Wu AH; Dampier CH; de la Chapelle A; Wolk A; Joshi AD; Burnett-Hartman A; Gsur A; Lindblom A; Castells A; Win AK; Namjou B; Van Guelpen B; Tangen CM; He Q; Li CI; Schafmayer C; Joshu CE; Ulrich CM; Bishop DT; Buchanan DD; Schaid D; Drew DA; Muller DC; Duggan D; Crosslin DR; Albanes D; Giovannucci EL; Larson E; Qu F; Mentch F; Giles GG; Hakonarson H; Hampel H; Stanaway IB; Figueiredo JC; Huyghe JR; Minnier J; Chang-Claude J; Hampe J; Harley JB; Visvanathan K; Curtis KR; Offit K; Li L; Le Marchand L; Vodickova L; Gunter MJ; Jenkins MA; Slattery ML; Lemire M; Woods MO; Song M; Murphy N; Lindor NM; Dikilitas O; Pharoah PDP; Campbell PT; Newcomb PA; Milne RL; MacInnis RJ; Castellví-Bel S; Ogino S; Berndt SI; Bézieau S; Thibodeau SN; Gallinger SJ; Zaidi SH; Harrison TA; Keku TO; Hudson TJ; Vymetalkova V; Moreno V; Martín V; Arndt V; Wei WQ; Chung W; Su YR; Hayes RB; White E; Vodicka P; Casey G; Gruber SB; Schoen RE; Chan AT; Potter JD; Brenner H; Jarvik GP; Corley DA; Peters U; Hsu L
Am J Hum Genet; 2020 Sep; 107(3):432-444. PubMed ID: 32758450
[TBL] [Abstract][Full Text] [Related]
7. How genetic risk contributes to autoimmune liver disease.
Ellinghaus D
Semin Immunopathol; 2022 Jul; 44(4):397-410. PubMed ID: 35650446
[TBL] [Abstract][Full Text] [Related]
8. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.
Carbone M; Nardi A; Flack S; Carpino G; Varvaropoulou N; Gavrila C; Spicer A; Badrock J; Bernuzzi F; Cardinale V; Ainsworth HF; Heneghan MA; Thorburn D; Bathgate A; Jones R; Neuberger JM; Battezzati PM; Zuin M; Taylor-Robinson S; Donato MF; Kirby J; Mitchell-Thain R; Floreani A; Sampaziotis F; Muratori L; Alvaro D; Marzioni M; Miele L; Marra F; Giannini E; Gaudio E; Ronca V; Bonato G; Cristoferi L; Malinverno F; Gerussi A; Stocken DD; Cordell HJ; Hirschfield GM; Alexander GJ; Sandford RN; Jones DE; Invernizzi P; Mells GF;
Lancet Gastroenterol Hepatol; 2018 Sep; 3(9):626-634. PubMed ID: 30017646
[TBL] [Abstract][Full Text] [Related]
10. A novel polygenic risk score improves prognostic prediction of heart failure with preserved ejection fraction in the Chinese Han population.
Han Y; Lu J; Chen B; Li X; Dai H; Zhang L; Yan X; Liu J; Zhang H; Fu X; Yu Q; Ren J; Cui H; Gao Y; Li J
Eur J Prev Cardiol; 2023 Sep; 30(13):1382-1390. PubMed ID: 37343143
[TBL] [Abstract][Full Text] [Related]
11. Phenotyping and auto-antibody production by liver-infiltrating B cells in primary sclerosing cholangitis and primary biliary cholangitis.
Chung BK; Guevel BT; Reynolds GM; Gupta Udatha DB; Henriksen EK; Stamataki Z; Hirschfield GM; Karlsen TH; Liaskou E
J Autoimmun; 2017 Feb; 77():45-54. PubMed ID: 27784538
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis.
Bossen L; Rebora P; Bernuzzi F; Jepsen P; Gerussi A; Andreone P; Galli A; Terziroli B; Alvaro D; Labbadia G; Aloise C; Baiocchi L; Giannini E; Abenavoli L; Toniutto P; Marra F; Marzioni M; Niro G; Floreani A; Møller HJ; Valsecchi MG; Carbone M; Grønbaek H; Invernizzi P
Liver Int; 2020 Jun; 40(6):1408-1414. PubMed ID: 32279422
[TBL] [Abstract][Full Text] [Related]
13. Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece.
Gatselis NK; Zachou K; Lygoura V; Azariadis K; Arvaniti P; Spyrou E; Papadamou G; Koukoulis GK; Dalekos GN; Rigopoulou EI
Eur J Intern Med; 2017 Jul; 42():81-88. PubMed ID: 28535947
[TBL] [Abstract][Full Text] [Related]
14. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants.
Dong J; Buas MF; Gharahkhani P; Kendall BJ; Onstad L; Zhao S; Anderson LA; Wu AH; Ye W; Bird NC; Bernstein L; Chow WH; Gammon MD; Liu G; Caldas C; Pharoah PD; Risch HA; Iyer PG; Reid BJ; Hardie LJ; Lagergren J; Shaheen NJ; Corley DA; Fitzgerald RC; ; Whiteman DC; Vaughan TL; Thrift AP
Gastroenterology; 2018 Apr; 154(5):1273-1281.e3. PubMed ID: 29247777
[TBL] [Abstract][Full Text] [Related]
15. Genetics and epigenetics in the pathogenesis of primary biliary cholangitis.
Joshita S; Umemura T; Tanaka E; Ota M
Clin J Gastroenterol; 2018 Feb; 11(1):11-18. PubMed ID: 29159718
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Wilde AB; Greverath LM; Steinhagen LM; de Chamorro NW; Leicht E; Fischer J; Herta T; Berg T; Preuss B; Klein R; Tacke F; Müller T
J Clin Med; 2022 Jan; 11(3):. PubMed ID: 35160133
[TBL] [Abstract][Full Text] [Related]
17. Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis.
Harms MH; Hirschfield GM; Floreani A; Mayo MJ; Parés A; Liberman A; Malecha ES; Pencek R; MacConell L; Hansen BE
JHEP Rep; 2021 Feb; 3(1):100191. PubMed ID: 33319187
[TBL] [Abstract][Full Text] [Related]
18. The genetics of primary biliary cholangitis.
Tanaka A; Leung PSC; Gershwin ME
Curr Opin Gastroenterol; 2019 Mar; 35(2):93-98. PubMed ID: 30601157
[TBL] [Abstract][Full Text] [Related]
19. Novel HLA-DRB1 alleles contribute risk for disease susceptibility in primary biliary cholangitis.
Li Y; Liu X; Wang Y; Zhou Y; Hu S; Yang H; Zhong W; Zhao J; Wang X; Chu H; Zheng Y; Zhang J; Zhou L; Wang B
Dig Liver Dis; 2022 Feb; 54(2):228-236. PubMed ID: 34016546
[TBL] [Abstract][Full Text] [Related]
20. A novel web-based online nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis-primary biliary cholangitis overlap syndrome.
Zhang Z; Wang J; Chen Y; Li Y; Zhu L; Wang H; Liu Y; Liu J; Yin S; Tong X; Yan X; Chen Y; Zhu C; Li J; Qiu Y; Wu C; Huang R
J Transl Autoimmun; 2023 Dec; 7():100215. PubMed ID: 37877134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
